Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
This 24-week study will compare the effects of adding the drug rosiglitazone (2mg and 4mg) or placebo to insulin in patients with Type 2 diabetes mellitus (non-insulin-dependent) who have not achieved their blood glucose goal using insulin alone. This study requires a total of seven visits during 28 weeks.
Epistemonikos ID: f9060503ee0bc612c37d945ea05f1e0f2b6516ee
First added on: May 04, 2024